"Eight Kilograms in Four Months. Early Satiety After Every Meal. A Father Who Died of Gastric Cancer. He Knew Something Was Wrong - and He Was Right."
Mr. Wang had spent his career teaching.
A 62-year-old retired middle school teacher, he had given four decades to his students - patient, methodical, attentive to the details that others missed. He had retired two years earlier with plans for his garden, his community volunteer work, and the slower rhythm of a life well earned. He was not the kind of man who ignored warning signs.
So when the early satiety started - the sensation of fullness after just a few bites, the vague discomfort in his upper abdomen that arrived without explanation and refused to leave - he paid attention. When his weight began to fall, he tracked it: two kilograms, then four, then six, then eight, over the course of four months. His father had been diagnosed with gastric cancer at 71. Mr. Wang knew what that history meant.
He made the appointment.
The gastroscopy found what he had feared: a Borrmann Type III ulcerative-infiltrative lesion in the upper gastric body near the cardia. The biopsy confirmed moderately differentiated adenocarcinoma, predominantly intestinal type by Lauren classification. The staging workup defined the extent: cT3N2M0, Stage IIIA. The tumor's upper margin was approximately 1.5 cm from the esophagogastric junction (EGJ). Multiple perigastric and celiac axis lymph nodes with short-axis diameters above 8 mm were identified. No distant metastases. CEA 12.8 ng/mL; CA19-9 34 U/mL.
His nutritional assessment showed mild malnutrition (NRS-2002 score 3). Performance status ECOG 1. The multidisciplinary team - gastroenterology, surgical oncology, medical oncology, radiology, and nutrition - reviewed his case together. Their consensus: rapid symptom progression and significant nutritional decline made upfront surgery the preferred strategy. The plan was laparoscopic radical total gastrectomy with D2 lymph node dissection, followed by adjuvant chemotherapy.
His family brought him to Shanghai and sought care from Dr. Yan Min, Chief of Gastrointestinal Surgery at Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, through China Medical Concierge - Shanghai (CMCS).
Understanding Gastric Cancer Surgery: Why Surgical Quality Determines Long-Term Survival
Gastric cancer is one of the most technically demanding malignancies to treat surgically. In Stage III disease, the difference between a curative resection and a palliative one is determined by the precision of the lymph node dissection, the quality of the anastomosis, and the experience of the surgical team:
- D2 lymph node dissection is the survival-determining standard for resectable gastric cancer - D2 dissection removes perigastric nodes (N1 stations) and nodes along the major arterial branches supplying the stomach (N2 stations); the minimum quality threshold is retrieval of at least 16 lymph nodes for accurate pathological staging; high-volume centers consistently retrieve more nodes and achieve lower positive margin rates
- Splenic hilar lymph node dissection (No. 10) for proximal gastric cancer requires specialized technique - spleen-preserving splenic hilar dissection requires meticulous dissection within the splenic arterial sheath and pancreatic tail fascial plane; splenectomy to facilitate nodal clearance increases operative morbidity without improving survival and is no longer recommended in guidelines
- Proximity to the EGJ demands precise resection margin planning - tumors within 2 cm of the EGJ require careful planning of the proximal resection margin; intraoperative frozen section assessment is the quality standard; a positive proximal margin (R1) is associated with dramatically worse survival and is not salvageable by adjuvant therapy
- Esophagojejunal anastomosis is the highest-risk step of total gastrectomy - anastomotic leak is the most feared complication, with a mortality rate of 20-40% when it occurs; the Overlap functional end-to-side anastomosis technique reduces anastomotic tension and has been associated with lower leak rates in high-volume centers
- ICG fluorescence imaging provides real-time blood supply assessment at the anastomotic site - intravenous ICG with near-infrared visualization allows the surgeon to assess esophageal stump perfusion before completing the anastomosis, identifying perfusion deficits before they cause postoperative leaks
- Laparoscopic total gastrectomy achieves equivalent oncological outcomes with superior recovery - high-quality randomized trial data from East Asian centers demonstrate equivalent R0 rates, lymph node retrieval, and long-term survival compared to open surgery in experienced hands, with significantly reduced blood loss, shorter hospital stay, and lower wound complication rates
- ERAS protocols reduce complications and accelerate recovery - early nasogastric tube removal, early mobilization, multimodal analgesia, and early oral feeding reduce postoperative complications and shorten hospital stay without increasing readmission rates
About Dr. Yan Min
Dr. Yan Min is the Chief of Gastrointestinal Surgery at Ruijin Hospital, Shanghai Jiao Tong University School of Medicine - a nationally designated gastric cancer treatment center. Nationally acclaimed for laparoscopic total gastrectomy and D2 lymph node dissection, Dr. Yan leads one of China's premier gastric cancer surgical programs, with a case volume and quality control infrastructure that places Ruijin Hospital among the top programs in Asia.
His clinical expertise spans:
- Laparoscopic radical gastrectomy for gastric cancer - laparoscopic total, subtotal, and proximal gastrectomy with D2 lymph node dissection for all stages of resectable gastric cancer; lymph node retrieval counts and R0 resection rates consistently exceed national quality benchmarks
- Spleen-preserving splenic hilar lymph node dissection (Station 10) - complete nodal clearance without splenectomy using the splenic arterial sheath approach and pancreatic tail fascial plane dissection
- EGJ tumors and Siewert classification management - surgical planning and resection for tumors at and near the EGJ, including margin assessment and reconstruction strategy selection
- Advanced laparoscopic reconstruction techniques - Overlap functional end-to-side esophagojejunostomy, Roux-en-Y reconstruction, and delta-shaped anastomosis with ICG fluorescence imaging for intraoperative perfusion assessment
- Multidisciplinary gastric cancer management - leadership of the Ruijin Hospital gastric cancer MDT integrating surgical oncology, medical oncology, gastroenterology, radiology, pathology, and nutrition
- ERAS implementation for major gastrointestinal surgery - institutional leadership of Enhanced Recovery After Surgery protocols achieving hospital stays and complication rates that benchmark favorably against international standards
The Case That Showed What a High-Volume Gastric Cancer Program Delivers
The Situation
A 62-year-old retired teacher. Eight kilograms of weight loss in four months. Early satiety and upper abdominal discomfort. A father who died of gastric cancer. Borrmann Type III adenocarcinoma of the upper gastric body, 1.5 cm from the EGJ. Stage IIIA (cT3N2M0). Mild malnutrition. Prior laparoscopic cholecystectomy creating adhesions in the hepatogastric space. MDT consensus: upfront laparoscopic radical total gastrectomy with D2 dissection, followed by adjuvant SOX chemotherapy. One question: is there a surgical team with the laparoscopic volume, the nodal dissection expertise, and the reconstruction technique to achieve R0 resection with spleen preservation and a safe esophagojejunal anastomosis in this patient?
The Assessment
Dr. Yan reviewed Mr. Wang's complete staging workup - the gastroscopy images, CT reconstruction, EUS staging, and nutritional assessment. He studied the tumor's relationship to the EGJ: the 1.5 cm proximal margin would require precise planning of the esophageal transection level. He noted the prior cholecystectomy and anticipated the adhesions in the hepatogastric space that would require careful dissection before standard operative planes could be established.
His operative strategy: five-port laparoscopic approach, D2 dissection with spleen-preserving Station 10 clearance using the splenic arterial sheath technique, Overlap functional end-to-side esophagojejunostomy with ICG fluorescence perfusion assessment, and intraoperative frozen section of the proximal margin.
"The tumor is close to the junction with the esophagus, which means we need to be precise about where we divide. We will check the margin under the microscope while you are still on the table. The lymph node dissection around the spleen is technically demanding, but we can clear those nodes without removing the spleen - and that matters for your recovery and your immune function. We will check the blood supply to the anastomosis with a fluorescence dye before we complete the join. Every step has a quality check."
The Procedure
Dr. Yan led the operative team in a laparoscopic radical total gastrectomy with D2 lymph node dissection - five-port approach, spleen-preserving Station 10 dissection, Overlap esophagojejunostomy, ICG fluorescence imaging, and intraoperative frozen section margin assessment.
The hepatogastric adhesions from the prior cholecystectomy were dissected methodically to re-establish correct fascial planes. The left lobe of the liver was suspended with a retraction suture to optimize EGJ exposure.
The D2 lymph node dissection proceeded systematically: Stations 1-7 (lesser curvature and left gastric artery), Stations 8a and 9 (common hepatic and celiac axis), Stations 11p and 11d (proximal and distal splenic artery). For the splenic hilar nodes (Station 10), Dr. Yan employed the splenic arterial sheath dissection with pancreatic tail fascial plane separation technique - achieving complete nodal clearance around the splenic hilum without injury to the splenic vessels and without splenectomy.
During dissection of the short gastric vessels, a small bleeding point was encountered and controlled precisely with bipolar electrocautery and a hemostatic clip. No conversion to open surgery.
The esophagus was transected at the planned level. Intraoperative frozen section confirmed R0 - negative proximal margin. The Overlap functional end-to-side esophagojejunostomy was constructed using a linear cutting stapler. Before completing the anastomosis, ICG fluorescence imaging confirmed adequate perfusion of the esophageal stump. Air insufflation and methylene blue testing confirmed no anastomotic leak.
Total operative time: 168 minutes. Estimated blood loss: 80 mL. Lymph nodes retrieved: 32 - double the minimum D2 quality threshold of 16.
The Recovery
Nasogastric tube and abdominal drain removed on postoperative day 1. Clear liquids on day 3, walking more than 200 meters per day. Soft diet and discharge on day 5 - weight loss of 2.1 kg from baseline, consistent with expected early physiological response.
Final pathology: pT3N2 (5/32 nodes positive), R0 resection, no lymphovascular invasion, no perineural invasion. Stage IIIA.
Adjuvant SOX chemotherapy (tegafur-gimeracil-oteracil + oxaliplatin) completed over six cycles with Grade I toxicity only - no dose reductions required.
At 12-month follow-up: weight recovered to 95% of preoperative baseline; no dysphagia, no reflux, no dumping syndrome; gastroscopy confirmed well-healed anastomosis; CEA normalized to 3.2 ng/mL. Returned to community volunteer work and light gardening.
His daughter called CMCS on the morning of his 12-month review: "He's back in his garden. He says the tomatoes are better than ever."
Outcome Summary
- ✅ R0 resection confirmed intraoperatively - frozen section of the proximal esophageal margin confirmed negative margins; final pathology confirmed R0, no lymphovascular invasion, no perineural invasion
- ✅ 32 lymph nodes retrieved - double the minimum D2 quality threshold of 16; 5/32 nodes positive, enabling accurate pathological staging
- ✅ Spleen-preserving Station 10 dissection completed - complete splenic hilar nodal clearance without splenectomy
- ✅ Anastomotic integrity confirmed intraoperatively - ICG fluorescence confirmed adequate esophageal stump perfusion; air and methylene blue testing confirmed no leak
- ✅ No conversion to open surgery - adhesions and intraoperative bleeding managed laparoscopically; estimated blood loss 80 mL
- ✅ ERAS pathway: discharged day 5 - nasogastric tube removed day 1; clear liquids day 3; no anastomotic leak, no wound complication, no readmission
- ✅ Weight recovered to 95% of baseline at 12 months - no dysphagia, no reflux, no dumping syndrome; CEA normalized 12.8 to 3.2 ng/mL
- ✅ World-class outcome at a fraction of the cost - laparoscopic total gastrectomy with D2 dissection, ICG fluorescence imaging, and ERAS pathway in Shanghai at a fraction of US or European costs
"He was 62. Stage IIIA gastric cancer, 1.5 cm from the esophageal junction. Eight kilograms of weight loss in four months. Dr. Yan Min at Ruijin Hospital performed a laparoscopic total gastrectomy with D2 dissection - 32 nodes retrieved, R0 margins confirmed, spleen preserved, anastomosis verified with ICG fluorescence imaging. He was discharged on day 5. Twelve months later, his weight had recovered to 95% of baseline, his CEA had normalized, and he was back in his garden."
Why Shanghai for Gastric Cancer Surgery?
- World-class outcomes at a fraction of the cost - laparoscopic total gastrectomy with D2 dissection, ICG fluorescence imaging, and ERAS pathway in Shanghai at a fraction of US or European costs
- Gastric cancer volume that drives expertise - China has the highest incidence of gastric cancer in the world; Ruijin Hospital's gastrointestinal surgery department performs a volume of gastric cancer resections that translates directly into surgical precision, nodal retrieval counts, anastomotic safety, and complication rates
- D2 dissection as the institutional standard - D2 lymph node dissection is the audited, quality-controlled standard for every eligible patient at Ruijin Hospital, not an aspiration
- Multidisciplinary gastric cancer program - every treatment decision is made by a coordinated MDT integrating surgical oncology, medical oncology, gastroenterology, radiology, pathology, and nutrition
- ERAS implementation that delivers on its promise - Mr. Wang's day-5 discharge after laparoscopic total gastrectomy reflects not just surgical skill but the full infrastructure of a high-performing ERAS program with audited outcomes
How CMCS Supports International Patients Seeking Gastric Cancer Surgery in Shanghai
- 🏥 Specialist access - direct connection to Dr. Yan Min and Ruijin Hospital's Department of Gastrointestinal Surgery
- 📋 Gastroscopy reports, CT/EUS staging, pathology slides, tumor marker results, and nutritional assessments translation and coordination
- 🗣️ On-site medical interpretation at every consultation, procedure, and follow-up
- ✈️ Travel and logistics coordination - visa, accommodation, airport transfers
- 📞 24/7 concierge support from first inquiry through every stage of treatment
- 🔄 Post-treatment follow-up - adjuvant chemotherapy coordination, surveillance gastroscopy scheduling, tumor marker monitoring, and nutritional rehabilitation support
📢 Subscribe to China Medical Concierge - Shanghai (CMCS)
We're delighted to offer you trusted medical tourism and personalized medical concierge services, giving you and your loved ones an extra pathway to quality care from China.
💬 Got questions? Drop a comment or DM us - we're always here to help!
📢 Have your own incredible medical story in China? Share it with us in the comments below!
#ChinaMedicalTour #AffordableHealthcare #MedicalTourismChina #ChinaHealthcare #MedicalConcierge #GastricCancer #StomachCancer #LaparoscopicSurgery #YanMin #RuijinHospital
🤝 Connect With CMCS
Struggling with long medical waitlists? Facing barriers to overseas treatment? China Medical Concierge - Shanghai (CMCS) helps international patients access premium medical care in Shanghai's top public and private hospitals, with end-to-end personalized support.
Contact us for international patient support:
📧 contract@medicalsh.com | 🌐 medicalsh.com
0 comments